UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037396
Receipt number R000042635
Scientific Title Advancing Care of Adrenal diseases and Adrenal Registry in ASIA
Date of disclosure of the study information 2019/07/17
Last modified on 2021/07/20 11:59:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Advancing Care of Adrenal diseases and Adrenal Registry in ASIA

Acronym

Adrenal Asia

Scientific Title

Advancing Care of Adrenal diseases and Adrenal Registry in ASIA

Scientific Title:Acronym

Advancing Care of Adrenal diseases and Adrenal Registry in ASIA

Region

Japan Asia(except Japan)


Condition

Condition

Pheochromocytoma, Cushing syndrome, subclinical Cushing syndrome, ACTH Independent Macronodular Adrenal Hyperplasia (AIMAH), Adrenocortical cancer, nonfunctioning adrenal tumor

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Nephrology Endocrine surgery Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In the context of the major intractable adrenal diseases of PA, PHEO, CS, SCS, AIMAH, ACC, and NFA, the study objectives are to:
1) build a disease registry as an infrastructure in developing new diagnostic and therapeutic methods, to create a disease cohort, and to establish a multicenter collaborative research network
2) build evidence on diagnostic tests, treatment, and disease prognoses to improve the quality of clinical practice and its guidelines.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

a. Basic patient information (age, height and weight at initial presentation, sex, past medical history, family history, what led to discovery, outcome, complications, symptoms etc.)
b. General laboratory test findings (blood counts, biochemistry, urinalyses etc.) *1
c. Endocrine test results (blood, urine) *2
d. Imaging findings (CT, MRI, FDG-PET, scintigraphy, etc.)
e. Treatment (surgery [Y/N, date], Medication [Y/N, drug, dose, method of administration,
duration of treatment], radiation [Y/N, date]

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients presenting to Kyoto Medical Center and other major medical centers across Japan and Asia who have been diagnosed with PA, PHEO, CS/SCS, AIMAH, ACC, or NFA between January 2006 and December 2018.

Key exclusion criteria

Not applicable

Target sample size

2400


Research contact person

Name of lead principal investigator

1st name Naruse
Middle name
Last name Mitsuhide

Organization

National Hospital Organization, Kyoto Medical Center

Division name

Clinical Research Institute for Endocrine and Metabolic Diseases

Zip code

6128555

Address

1-1Fukakusa-Mukaihatacho, Fushimiku, Kyoto, 612-8555, Japan

TEL

075-641-9161

Email

asiaoceania.panet@gmail.com


Public contact

Name of contact person

1st name Naruse
Middle name
Last name Mitsuhide

Organization

National Hospital Organization, Kyoto Medical Center

Division name

Clinical Research Institute for Endocrine and Metabolic Diseases

Zip code

6128555

Address

1-1Fukakusa-Mukaihatacho, Fushimiku, Kyoto, 612-8555, Japan

TEL

075-641-9161

Homepage URL


Email

asiaoceania.panet@gmail.com


Sponsor or person

Institute

National Hospital Organization, Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization, Kyoto Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization, Kyoto Medical Center

Address

1-1Fukakusa-Mukaihatacho, Fushimiku, Kyoto, 612-8555, Japan

Tel

075-641-9161

Email

asiaoceania.panet@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖マリアンナ医科大学 横浜市西部病院 (神奈川県)
市立札幌病院(北海道)
国立国際医療研究センター(東京都)
京都大学(京都府)
鳥取大学(鳥取県)
兵庫医科大学(兵庫県)
National Taiwan University Hospital, Taipei, Taiwan
Chong Hua Hospital, Cebu City, Philippines
North Shore Hospital, Auckland, New Zealand
University Kebangsaan Malaysia Medical Center, Selangor, Malaysia
Yonsei University College of Medicine, Seoul, Korea
Fatmawati General Hospital, a tertiary /referral government Hospital , teaching hospital for internal medicine resident of University of Indonesia, Jakarta, Indonesia
Seth G.S. Medical College & KEM Hospital, Parel Mumbai, India
Hypertension Center of Xinjiang Provincial General Hospital, Xinjiang Hypertension Institute, Urumqi, China


Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1174

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 08 Month 10 Day

Date of IRB

2017 Year 09 Month 19 Day

Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Multicenter, observation study.


Management information

Registered date

2019 Year 07 Month 17 Day

Last modified on

2021 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042635


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name